Literature DB >> 24673081

Salt intake in Eastern Saudi Arabia.

A M Alkhunaizi, Jishi H A Al, Sadah Z A Al.   

Abstract

High salt intake has been associated with adverse side-effects such as hypertension and cardiovascular disease. The amount of salt intake among the population of Saudi Arabia is not known. The objective of this study was to estimate the salt intake among residents of the Eastern region of Saudi Arabia by measuring 24-hour urinary sodium excretion. Urine samples were collected from 130 individuals aged over 14 years for measurement of levels of sodium and other electrolytes. A total of 87 samples met the criteria for accuracy and were analysed. Total mean 24-hour sodium excretion for the group was 140 (SD 49) mEq [153 (SD 52) mEq for males and 118 (SD 37) mEq for females]. These values exceed the recommended daily intake of sodium and may contribute to the risk of developing hypertension and cardiovascular disease in Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24673081

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.

Authors:  Ibrahim M Gosadi
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

2.  Dietary salt consumption and the knowledge, attitudes and behavior of healthy adults: a cross-sectional study from Jordan.

Authors:  Izzat Alawwa; Rajaa Dagash; Akram Saleh; Abdelaziz Ahmad
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

3.  National survey to estimate sodium and potassium intake and knowledge attitudes and behaviours towards salt consumption of adults in the Sultanate of Oman.

Authors:  Adhra Al-Mawali; Lanfranco D'Elia; Sathish Kumar Jayapal; Magdi Morsi; Waleed Nasser Al-Shekaili; Avinash D Pinto; Hilal Al-Kharusi; Zainab Al-Balushi; John Idikula; Ayaman Al-Harrasi; Francesco P Cappuccio
Journal:  BMJ Open       Date:  2020-10-23       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.